OR WAIT 15 SECS
PHILADELPHIA, 17 April 2009 - ERT, a leading provider of centralized ECG and eClinical technology, ePRO and services to the biopharmaceutical, medical device and related industries, today announces the launch of its newly designed website at www.ERT.com following an extensive and successful company rebrand. The new and improved website provides an online experience detailing information on ERT's portfolio of clinical trial solutions as well as all the latest company news and events, which serve to educate customers and facilitate inquiries.
Building on its long established pedigree and reputation in the industry, ERT has adopted an entirely new identity and brand image following extensive external and internal assessment. As a result the website has undergone a complete redesign that now enables users to navigate the site quickly and easily. The contemporary and intuitive design of the website underpins the recently launched brand strategy and new visual identity.
The new website is aimed at giving visitors a better understanding of ERT and its products and services. Comprehensive information is provided on the four new sub-brands of its industry-leading products and services, including ERT Cardiac Safety Solutions, ERT EDC Solutions, ERT ePRO Solutions and ERT Clinical Research Consulting Group. A dedicated resource centre includes a white paper library and product demonstrations, while a separate news and events section provides users and media contacts with clear up-to-date information.
Michael McKelvey, President and CEO of ERT, said: "2009 is an exciting year for ERT as we continue to move forward in establishing the company as the most experienced and reliable partner in products and services for clinical trials. In line with our new brand strategy, we wanted to create a more
engaging online experience for our customers and the new website reflects the dynamic new company image and the ERT commitment to quality, customer satisfaction and getting the job done right."
For further information on ERT and its technology and services please email info@ERT.com, call +1 +1 215 972 0420 or visit www.ERT.com.
Based in Philadelphia, PA ERT (eResearchTechnology, Inc.) (www.ERT.com) is a provider of technology and services to the global biopharmaceutical and medical device industries. The company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis and distribution of clinical data in all phases of clinical development.
Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements, including, but not limited to, 2009 financial guidance, involve a number of risks and uncertainties such as the Company's
ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of
projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or